Details:

Corporate Authors:
Centers for Disease Control and Prevention (U.S.) ;
Description:
Friday, April 08, 2005, 18:05 EDT (6:05 PM EDT) CDCHAN-00226-2005-04-08-UPD-N In follow-up to the previous notification of S. marcescens bacteremia associated with contaminated magnesium sulfate from PharMEDium (March 18, 2005), the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration have obtained new information in their ongoing investigation. Because evidence exists to implicate at least three contaminated PharMEDium lots of magnesium sulfate, CDC recommends that magnesium sulfate solution from Pharmedium not be administered to patients until the scope of contamination can be determined. PharMEDium is voluntarily recalling all 50 ml. magnesium sulfate admixtures. These 50 ml preparations will not be available until further notice.
Subject:
[+]
Bacteremia
Cardiac Surgical Procedures
Cardiovascular Agents/adverse Effects
Disease Outbreaks
Drug Compounding/standards
Drug Contamination
Magnesium Sulfate/adverse Effects
Risk Factors
Serratia Infections

Series:
HAN ; 226;
Document Type:
HAN Health Update ;
Place as Subject:
United States ;
Collection(s):
Health Alert Network (HAN)
Main Document Checksum:
[+]
urn:sha256:f32ea349a4a705f0a75a1406ad80616c14b6e6b367020f04c9245e37d238eae7
File Type:

Supporting Files

• No Additional Files

More +